SCHEMBL14629686

SCHEMBL14629686

Oc1ccc(Sc2ncc[nH]2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.48
GCK P35557 1/20 0.38
FDPS P14324 1/20 0.37
FBP1 P09467 1/20 0.36
TXN P10599 1/20 0.35
TXNRD1 Q16881 1/20 0.35
CHEK1 O14757 1/20 0.35
PRKD3 O94806 1/20 0.35
PAK4 O96013 1/20 0.35
PDGFRA P16234 1/20 0.35
LTK P29376 1/20 0.35
MAP2K2 P36507 1/20 0.35
MAPK8 P45983 1/20 0.35
CDK8 P49336 1/20 0.35
RPS6KA3 P51812 1/20 0.35
PRKX P51817 1/20 0.35
NEK2 P51955 1/20 0.35
LIMK1 P53667 1/20 0.35
CDK5 Q00535 1/20 0.35
PRKCQ Q04759 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8363007 0.81 NISCH (0.48) GCKFBP1TXNTXNRD1ALDH1A1
SCHEMBL10395765 0.81 L3MBTL1 (0.46) FBP1ALDH1A1KDM4EMEN1LMNA
SCHEMBL5032699 0.80 MTOR (0.45) GCKFDPSTXNTXNRD1MTOR
Hydrochloric Acid SCHEMBL10395359 0.79 L3MBTL1 (0.49) GCKALDH1A1KDM4EMEN1LMNA
SCHEMBL14599593 0.77 CYP1A2 (0.37) GCKFDPSTXNTXNRD1CYP3A4
SCHEMBL11201194 0.77 HAO1 (0.45) FBP1DHFRCYP3A4
SCHEMBL1740306 0.76 TXN (0.45) GCKFDPSTXNTXNRD1BRAF
SCHEMBL57681 0.74 MEN1 (0.51) GCKDHFRALDH1A1SMN1; SMN2KDM4E
SCHEMBL11727794 0.73 GCK (0.49) GCKFDPSTXNTXNRD1AURKB
Hydrochloric Acid SCHEMBL10394645 0.73 MEN1 (0.50) GCKDHFRALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021483-A1 Amidine derivatives for treating amyloidosis NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021483-A1 Amidine derivatives for treating amyloidosis APP, IAPP, GRN NR1H2 1227/4885GCK 2955/4885FDPS 1572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.